The Achilles' heel of coronaviruses: targeting the 5' Polyuridines tract of the antigenome to inhibit Mouse coronavirus-induced cell death
Abstract
The current coronavirus pandemic situation is worsened by the rapidly-spreading SARS-CoV-2 virus variants. Identification of viral targets that are indispensable for the virus can be targeted to inhibit mutation-based new escape variant development. The 5-polyU tract of the antigenome offers such a target. Host cells do not harbor 5-polyU tracts on any of their transcripts, making the tract an attractive, virus-specific target. Inhibiting the 5-polyU can limit the use of the tract as template to generate 3 polyA tails of +RNAs of coronaviruses. Here, a modified DNA oligo with 3 polyAs is used to target the 5-polyU tract in mouse coronavirus (MHV-A59). The oligo treatment in mouse 17CL-1 cells infected with MHV-A59 significantly prevented virus-induced cell deaths. This proof-of-concept result shows a unique mode of action against mouse coronavirus without affecting host cells, and can be used for the development of novel classes of drugs that inhibit coronavirus infection in host cells, specifically by the COVID-19-causing virus SARS-CoV-2. In addition, as the 5-polyU tract is immediately generated upon infection, the tag can also be targeted for reliable early detection of viral infection.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Crippled Coronavirus: 5'-PolyU targeted Oligo prevents development of infectious Virions
H. Ullah, S. Averick, Q. Tang·bioRxiv·Mar 4, 2022
- Physiologic RNA Targets and Refined Sequence Specificity of Coronavirus EndoU
R. Ancar, Y. Li, … D. L. Barton·bioRxiv·May 20, 2020
- Antisense oligonucleotide to SARS-Cov-2 trs gene: antiviral activity on an in vitro model and possibilities of vital and postmortem diagnosis of COVID-19.
A. N. Goryachev, A. A. Shtro, … A. S. Goryacheva·bioRxiv·Aug 13, 2022
- Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers.
K. Rosenke, S. Leventhal, … D. A. Stein·bioRxiv·Sep 29, 2020
- Manipulation of the unfolded protein response: a pharmacological strategy against coronavirus infection
L. Echavarria-Consuegra, G. M. Cook, … N. Irigoyen·bioRxiv·Mar 19, 2021
- Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
M. Zafferani, C. Haddad, … A. E. Hargrove·bioRxiv·Dec 5, 2020